SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-08-002696
Filing Date
2008-08-06
Accepted
2008-08-06 16:47:54
Documents
4
Period of Report
2008-07-29
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K w64843e8vk.htm 8-K 9896
2 EX-99.1 w64843exv99w1.htm EX-99.1 927715
3 GRAPHIC w64843w6484301.gif GRAPHIC 7447
4 GRAPHIC w64843w6484302.gif GRAPHIC 2357
  Complete submission text file 0000950133-08-002696.txt   952898
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 08995431
SIC: 2834 Pharmaceutical Preparations